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Abstract. NO is present in the blood at 10−7 M under physiological conditions, but at concentrations higher than 10−6 M
during inflammatory disease states. The aim of this study was to characterize what are the effects of these different NO concen-
trations on erythrocyte structural and functional properties. Blood was collected from eleven healthy men and incubated with
SpermineNONOate in order to expose it during incubation time to NO concentrations between 10−7 M and 10−3 M. We mea-
sured erythrocyte aggregation and deformability, membrane lipid peroxidation and fluidity, p50, hemoglobin, oxyhemoglobin,
methemoglobin concentrations and plasma pH, pO2, pCO2, Na+, K+ and Ca2+. When blood was exposed to NO 10−7 M ery-
throcyte deformability increase and p50 decrease. In presence of NO 10−5 M lipid fluidity and p50 decrease. When blood was
exposed to NO 10−3 M methemoglobin concentration increase and erythrocyte deformability and p50 decrease but membrane
fluidity and lipid peroxidation were similar to control. In conclusion, dependent of NO concentrations there is different effects
on erythrocytes structural and functional properties.
1. Introduction
Nitric oxide is an endogenous mediator synthesized and released constitutively by vascular endothelial
cells to underneath smooth muscle cells and to the blood [14]. Immunologic and inflammatory stimuli
have been shown to induce the expression of an isoenzyme of NO synthase (iNOS) in endothelial cells
and monocytes [34]. While NO is present in the blood at 10−7 M when produced constitutively un-
der physiological conditions, it is present at concentrations higher than 10−6 M during inflammatory,
infectious and degenerative disease states [7].
Erythrocytes are blood cells and thus exposed continuously to NO and its metabolites. The relative
concentrations of NO and its metabolites, as well as the exact chemical nature of those are influenced by
the “redox status” of the cells [2].
Some of NO produced by vascular endothelial cells may reach the erythrocytes, diffuse across ery-
throcyte membrane and react with either oxyhemoglobin to form nitrate and methemoglobin, or with
hemoglobin to form nitrosylhemoglobin, or with 93-cysteine residue of the globin β-subunit to form
S-nitrosohemoglobin [9,18,22].
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Eiserich et al. (1995) demonstrated that NO reacts directly with tryptophan and tyrosine radicals in
amino acids, peptides and proteins [6]. Additionally, NO has the capacity to modulate the activity of pro-
teins through reversible reaction with available functional groups, notably Fe and thiols. S-nitrosylation
of glyceraldehyde-3-phosphate dehydrogenase promotes ADP-ribosylation of the enzyme and is associ-
ated with inhibition of its activity [31].
In the aqueous phase of plasma, NO may react with molecular oxygen to form nitrite, or with superox-
ide anion to form peroxynitrite (ONOO−). NO reacts with superoxide at an almost near-diffusion-limited
rate of 6.7 × 109 M−1 s−1 and formation of peroxynitrite will only occur where the appearance rate of
NO is equal or lower than that of superoxide formation [8].
Peroxynitrite is a very reactive molecule interacting with cell membrane and other components. It
was shown to oxidize glutathione and protein cysteine residues, potentially depleting cells of antioxidant
defenses [28]. Peroxynitrite and/or peroxynitrous acid will also initiate the oxidation of unsaturated fatty
acids [38]. Peroxynitrite also exhibits reactivity with protein tyrosine residues [13]. Peroxynitrite can
react with other components in cells besides protein tyrosine residues, but these competing reactions may
be minimized in vivo because of the presence of CO2, which catalyzes peroxynitrite-mediated protein
nitration [45].
Starzyk et al. (1997) have found that during an acute phase of lipopolysacharide (LPS) action in rats,
the excessive amount of NO originated leads to a decrease of erythrocyte deformability, and L-NAME
(a NOS inhibitor) exerts a protective effect on LPS-impaired deformability [43]. Bateman et al. (2001)
confirmed these data using aminoguanidine, an iNOS inhibitor which prevented the overproduction of
systemic NO, accumulation of NO within erythrocytes and also prevented erythrocyte deformability
in septic rats [1]. On the other hand, basal release of NO is important for maintaining erythrocyte de-
formability at the physiological range, because lowering basal NO levels with NOS inhibitors leads to
impairment of erythrocyte deformability [43].
These earlier studies support the idea that NO effects on cells and specifically on erythrocytes depends
on its concentrations. The aim of this study was to characterize the effects of a range of NO concentrations
between 10−7 M and 10−3 M on erythrocyte hemorheological properties (aggregation and deformabil-
ity), membrane dynamic and structure (ions permeability, lipid peroxidation and membrane fluidity) and
oxygen hemoglobin affinity.
2. Materials and methods
2.1. Materials
SpermineNONOate was purchased from Calbiochem. 1,6-diphenyl-1,3,5-hexatriene was purchase
from Molecular Probes.
2.2. Subjects and blood collection
Blood was collected from a forearm vein of ten healthy caucasian males (22 ± 3 years old). All the
subjects were students at the Faculty of Medicine of Lisbon. All the subjects gave their informed consent.
Blood was collected to tubes with heparin 10 UI/ml according to the guidelines for measurement of blood
viscosity and erythrocyte deformability [16].
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2.3. Experimental procedure
After blood collection, blood was divided into six aliquots each one with 2 milliliters and centrifuged
at 9 600g for 1 minute in a Biofuge 15 centrifuge (Heraeus, Sepatech). Then 40 µl of plasma was taken
from each aliquot and replaced with the same volume of SpermineNONOate solutions in order to obtain
SpermineNONOate final concentrations of 10−7, 10−6, 10−5, 10−4 and 10−3 M. The remaining aliquot
served as control. All aliquots were incubated at 37◦C for 40 minutes, based on previous information
about half-life of SpermineNONOate [19]. As each molecule of SpermineNONOate donates two mole-
cules of NO, and its half-life is of 39 minutes, at the end of the incubation time, samples were exposed
to NO concentrations equal to initial SpermineNONOate concentrations. Based on these data what we
know is the cumulative NO concentration but not the instantaneous one.
2.4. Membrane lipid fluidity
Membrane lipid fluidity was determined by measuring fluorescence anisotropy with 1,6-diphenyl-
1,3,5-hexatriene (DPH) probe for hydrophobic zone of membrane [40]. Higher values of fluores-
cence anisotropy are related with lower fluidity. Ten microliters of packed erythrocytes was ressus-
pended in phosphate buffer 155 mM with DPH 2.2 mM. The fluorescence anisotropy (λex = 465 nm,
λem = 465 nm) of a 1/10 dilution of last solution was measured using a spectrofluorometer Hitachi
F3000 (Hitachi, Japan), according the method described by Shirilo et al. (1981).
2.5. Membrane lipid peroxidation
Malonyldialdehyde (MDA), and end product of fatty acid lipid peroxidation, like other aldehydes
formed during lipid peroxidation, can react with thiobarbituric acid (TBA) to form a colored complex
that has maximum absorvance at 532 nm. The TBA reactivity of erythrocytes was a measure of mem-
brane lipid peroxidation and was determined by the Stocks and Dormandy modified method of TBA-
reactivity [17]. In this procedure, 0.2 ml of packed erythrocytes were suspended in 0.8 ml of phosphate-
buffered saline made up of 8.1 g NaCl, 2.302 g Na2HPO4 and 0.194 g NaH2PO4, per liter, pH 7.4. To
this, 0.5 ml of 30% trichloroacetic acid was added. Tubes were vortexed and allowed to stand in ice for
at least 2 h. Tubes were centrifuged at 670g for 15 minutes using the centrifuge Sorvall R© TC6. One
milliliter from supernatant of each tube was transferred to another tube and 0.075 ml of EDTA 1 M and
0.25 ml of TBA 1%–NaOH 0.05 nM were added. Tubes were mixed and kept in a 100◦C water bath for
15 minutes. After that tubes were centrifuged 2 minutes at 18 000g using the centrifuge Biofuge 15 (Her-
aeus Sepatech). Absorvance was read at 532 nm in spectrophotometer Beckman Model 35 after tubes
were cooled to room temperature. The MDA concentration was expressed as nmol/1010 erythrocytes.
The erythrocyte counts were done in Abott cell-Dyn 1600.
2.6. Erythrocyte deformability
Erythrocyte deformability was determined using the Rheodyn SSD laser difractometer from Myrenne
(Roetgen, Germany).
The Rheodyn SSD difractometer determines RBC deformability by stimulating the shear stresses ex-
erted by the blood flow and vascular walls on the erythrocytes [41]. Erythrocytes are suspended in a
viscous medium and placed between a rotating optical disk and a stationary disk, where they are going
to be subjected to well defined shear stresses, that forces the erythrocytes to deform to ellipsoids and
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align with the fluid shear stress. If a laser beam is allowed to pass through the erythrocyte suspension
a diffraction pattern appears on the opposite end. That diffraction pattern will be circular with resting
erythrocytes, but becomes elliptical with deformed erythrocytes. The light intensity (lum) of the diffrac-
tion pattern is measured at two different points (A and B), equidistant from the center of the image. The
erythrocyte elongation index (EEI), in percentage, is obtained according to the following formula:
EEI (%) = lumA− lumB
lumA+ lumB
× 100.
2.7. Erythrocyte aggregation
Erythrocyte aggregation was determined using the MA1 aggregometer from Myrenne (Roetgen, Ger-
many). The MA1 aggregometer consists of a rotative cone-plate aggregometer, that disperses the sample
by high shear stress (600/s), and a photometer that determines the extent of aggregation. The intensity of
light, exerted by a light emitting diode, is measured after transmission through the blood sample using
a photodiode. The aggregation was determined in stasis during 10 seconds, after dispersion of the blood
sample [37].
2.8. K+, Na+, Ca2+ plasma concentrations, pH, oxygen pressure (pO2), carbon dioxide pressure
(pCO2), hemoglobin (Hb), oxyhemoglobin (O2Hb), carboxyhemoglobin (COHb), methemoglobin
(MetHb), hemoglobin oxygen saturation (sO2) and oxygen tension at half saturation of blood (p50)
Plasma pH, pO2, pCO2, Na+, K+ and Ca2+ concentrations were determined with the ABL505 elec-
trode system from Radiometer (Copenhagen, Denmark). Hb, O2Hb, COHb, MetHb, and SO2 were de-
termined with the Osm3 hemoximeter from Radiometer. p50, an index of hemoglobin oxygen affinity,
is determined by ABL505 electrode system connected to Osm3 hemoximeter, both from Radiometer.
ABL505 calculates the value of p50 mathematically, based on the values of carboxyhemoglobin, methe-
moglobin and the oxygen dissociation curve.
2.9. Statistical analysis
Data are presented as means ± standard error. Student’s t test for paired observations was used to
evaluate statistical significance of differences between the studied parameters. Statistical significance
was considered for values of p < 0.05.
The statistical analysis was performed using the following software SPSS 10 (SPSS Inc.).
3. Results
3.1. Effects of nitric oxide on erythrocyte membrane lipid fluidity and peroxidation (Fig. 1)
Membrane lipid fluidity was assessed by measuring fluorescence anisotropy of DPH probe on ery-
throcyte membrane being the control value 0.284 ± 0.009 (au). When we incubate blood with Sper-
mineNONOate 10−7 M, for example, we know that blood was exposed to a total NO concentration of
10−7 M. The same we suppose real to other concentrations of SpermineNONOate. As showed in Fig. 1,
the mean fluorescence anisotropy remained approximately the same when blood was incubated with
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Fig. 1. Malonyldialdehyde (MDA) concentration values and fluorescence anisotropy values obtained with DPH probe intro-
duced on human erythrocytes membrane after incubation without and with SpermineNONOate (SpNO) concentrations between
10−7 M and 10−3 M during 40 minutes.
SpermineNONOate 10−7 M and 10−6 M. However when blood was incubated with SpermineNONOate
10−5 M, we observed a significant increase of fluorescence anisotropy to 0.308 ± 0.005 (au), p < 0.04.
An increase of fluorescence anisotropy of DPH probe means a decrease of lipid fluidity of hydrophobic
zone of erythrocyte membrane. Increasing the concentration of SpermineNONOate there was a decrease
of fluorescence anisotropy, what means an increase of lipid fluidity to values similar to the control ones.
The control values of MDA concentrations on erythrocytes after 40 minutes at 37◦C was 3.01 ±
0.21 nmol/1010 erythrocytes. Although there were not significant changes of lipid peroxidation in pres-
ence of different concentrations of SpermineNONOate the obtained profile was similar to that of mem-
brane fluidity (DPH fluorescence anisotropy) as showed in Fig. 1.
3.2. Effects of nitric oxide on erythrocyte deformability and aggregation
The elongation index of erythrocytes measured at eight different shear stresses gives us an idea of
erythrocyte deformability at different places of circulation. When blood was incubated in presence of
SpermineNONOate 10−7 M there is a significant increase of erythrocyte deformability at high shear
stress values (Table 1). On the other hand when blood was incubated with SpermineNONOate 10−3 M
there is a significant decrease of erythrocyte deformability at low shear stress values.
The erythrocyte aggregation index with a control value of 14.32 ± 0.66 (nd) did not significantly
change when blood was incubated with different SpermineNONOate concentrations.
3.3. Effects of nitric oxide on plasma concentrations of sodium, potassium and calcium and plasma pH
(Table 2)
There is a slight but significative decrease of sodium, potassium and calcium concentrations in the
presence of all SpermineNONOate concentrations studied ( p < 0.05), except for SpermineNONOate
10−3 M in presence of which the increase of K+ concentration verified is not significative.
pH is increased in presence of SpermineNONOate 10−7 M, is similar to control for SpermineNONOate
10−6 M but significantly increased for higher SpermineNONOate concentrations.
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Table 1
Values of erythrocyte elongation index (%) at shear stress values between 0.3 Pa and 60 Pa after in vitro incubation of blood
aliquots in absence and presence of different concentrations of SpermineNONOate (SpNO)
Shear stress Control SpNO 10−7 M SpNO 10−6 M SpNO 10−5 M SpNO 10−4 M SpNO 10−3 M
values
0.3 Pa 2.61± 0.43 2.58± 0.44 2.55± 0.40 2.63± 0.47 1.94± 0.341 2.08± 0.30
0.6 Pa 4.40± 0.31 4.19± 0.552 4.18± 0.52 4.23± 0.43 4.48± 0.48 3.83± 0.303
1.2 Pa 12.46± 0.77 11.86± 0.59 11.99± 0.74 11.82± 0.73 11.74± 0.73 11.66± 0.674
3.0 Pa 26.93± 0.80 26.63± 0.65 26.71± 0.82 26.12± 0.95 26.48± 0.79 26.20± 0.75
6.0 Pa 37.27± 0.89 37.17± 0.78 37.17± 0.83 35.97± 1.47 37.27± 0.93 37.19± 0.74
12 Pa 44.82± 1.42 45.22± 1.18 44.82± 1.23 43.55± 1.84 44.98± 1.28 45.27± 1.07
30 Pa 48.02± 1.84 48.96± 1.601 48.43± 1.60 46.94± 1.99 48.65± 1.67 48.82± 1.42
60 Pa 47.18± 1.89 48.45± 1.581 47.78± 1.72 46.37± 2.06 47.91± 1.61 47.81± 1.45
1p < 0.04; 2p < 0.001; 3p < 0.01; 4p < 0.05.
Table 2
Values of plasma concentrations of Na+, K+, Ca2+, pH, pO2 and pCO2, and blood hemoglobin, oxyhemoglobin and methe-
moglobin concentrations after in vitro incubation of blood aliquots in absence and presence of different concentrations of
SpermineNONOate (SpNO)
Control SpNO 10−7 M SpNO 10−6 M SpNO 10−5 M SpNO 10−4 M SpNO 10−3 M
[Na+] (mmol/l) 139.9± 0.5 137.8± 0.51 138.2± 0.41 138.2± 0.51 137.7± 0.71 137.7± 0.81
[K+] (mmol/l) 3.64± 0.08 3.51± 0.071 3.48± 0.061 3.51± 0.071 3.52± 0.071 3.73± 0.08
[Ca2+] (mmol/l) 1.16± 0.02 1.13± 0.021 1.14± 0.022 1.14± 0.022 1.14± 0.022 1.12± 0.021
pH 7.34± 0.01 7.36± 0.011 7.34± 0.01 7.35± 0.013 7.37± 0.011 7.38± 0.021
pO2 (mmHg) 41.79± 1.95 42.59± 1.97 43.50± 2.202 43.87± 2.542 42.08± 2.29 39.87± 3.14
pCO2 (mmHg) 47.58± 1.27 43.56± 1.131 46.23± 1.04 45.16± 1.332 43.21± 0.761 43.93± 1.602
[Hb] (g/dl) 14.27± 0.30 14.33± 0.24 14.39± 0.27 14.22± 0.34 14.26± 0.28 14.33± 0.27
O2Hb (%) 74.92± 2.53 77.29± 1.92 76.76± 2.20 77.83± 2.60 76.38± 2.65 72.67± 3.58
MetHb (%) 1.48± 0.06 1.49± 0.05 1.48± 0.04 1.58± 0.06 1.8± 0.132 4.97± 1.442
1p < 0.001; 2p < 0.03; 3p < 0.005.
3.4. Effects of nitric oxide on pO2 and pCO2 (Table 2)
PO2 values increased in the aliquots incubated with SpermineNONOate 10−5 M and 10−6 M, relatively
to control ( p < 0.001). pCO2 values decreased in the aliquots incubated with SpermineNONOate 10−7,
10−5, 10−4 and 10−3 M ( p < 0.001).
3.5. Effects of nitric oxide on methemoglobin concentration (Table 2) and p50 value (Fig. 2)
The methemoglobin concentration remained approximately similar to control value (1.48 ± 0.04%)
when blood was incubated with SpermineNONOate 10−7 M to 10−4 M but had a large increase when
blood was incubated with SpermineNONOate 10−3 M (4.97 ± 1.44%, p < 0.04).
The oxygen pressure corresponding to half saturation of hemoglobin (p50) traduces the affinity of
hemoglobin to oxygen. The p50 value of control aliquot was 25.56 ± 0.49 mmHg. When blood was
incubated with SpermineNONOate 10−7 M the p50 value decreases (24.70 ± 0.39 mmHg, p < 0.04),
but with SpermineNONOate 10−6 M, the p50 value is similar to control aliquot. For SpermineNONOate
concentrations 10−5, 10−4 and 10−3 M the p50 value decreases relatively to control with a progressive
profile ( p < 0.02) (Fig. 2).
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Fig. 2. p50 values (mean ± SE) determined on blood aliquots after incubation without and with SpermineNONOate (SpNO)
concentrations between 10−7 M and 10−3 M during 40 minutes.
4. Discussion
The results presented here show that nitric oxide has different effects on erythrocyte structural and
functional properties depending of its concentration in the blood.
When blood aliquots were incubated with SpermineNONOate concentrations of 10−7 M there was
a slight increase of erythrocyte deformability relatively to control aliquots for high shear stress values
(30 and 60 Pa) but no significative changes were verified on membrane lipid fluidity and lipid perox-
idation. These last results support the hypothesis that in this in vitro model at this SpermineNONOate
concentrations, there is scarce formation of peroxynitrite, which after protonation (pKa = 6.8) forms
peroxynitric acid that generates by homolytic and heterolytic cleavage the highly reactive radicals OH.,
NO.2 and NO
+
2 , capable of oxidizing the membrane lipids [3]. Supposing that NO reaction with super-
oxide could not be the major route, it can react with O2 forming nitrite, with plasma proteins forming
nitrosothiols like S-nitrosoalbumin, with erythrocyte membrane proteins and reacts with deoxy- and
oxyhemoglobin [20,24,42,47]. The slight increase of erythrocytes elongation index mentioned above
can be induced by S-nitrosylation of membrane skeleton proteins modulating erythrocyte deformabil-
ity. If this was the case, S-nitrosylation would modify the cytoskeleton proteins interactions in order to
increase the erythrocyte deformability. However the effect of S-nitrosylation of erythrocyte cytoskele-
ton proteins was not studied yet. Based on our data that when NO is present in concentrations around
10−7 M there is no relevant changes on membrane lipid fluidity and peroxidation and an increase of
erythrocyte deformability we hypothesize that these conditions could facilitate erythrocyte passage in
narrow capillaries and then tissue oxygenation. However shear stress values of 30 and 60 Pa are very
increased relatively to physiologic values of about 10 Pa in capillaries where erythrocyte deformability
is determinant for normal blood flow [30]. On the other hand tissue oxygenation is also modulated by
oxygen–hemoglobin affinity [25] assessed in this study by p50 value which decrease relatively to con-
trol value when blood was incubated with SpermineNONOate 10−7 M, returning to values similar to
control for SpermineNONOate 10−6 M. A decrease of p50 means an increase of hemoglobin–oxygen
affinity and then a decrease of oxygen delivery to tissues [29]. This decrease of p50 can be justified
by the increase of plasma pH and decrease of pCO2 verified when blood aliquots were incubated with
SpermineNONOate 10−7 M (Table 1). According with these data, Puscas et al. [35] previously described
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inhibition of erythrocyte carbonic anhydrase I by nitric oxide which consequently decrease the pCO2 and
subsequently increase the pH. In what concerns methemoglobin formation there is no changes comparing
blood aliquots incubated with SpermineNONOate 10−7 M, 10−6 M and control aliquot.
Additionally, another mechanism may be hypothesized to explain data referred above. When NO con-
centration is lower than or equal to that of superoxide anion it has been postulated that there could be
formation of peroxynitrite anion [12]. The reason why there is no changes in lipid peroxidation and
consequently membrane fluidity may be the reaction between peroxynitrite and CO2 forming a highly
reactive nitrosoperoxocarbonate (ONOOCO−2 ) [36]. Since it is less stable than ONOO−, it has a much
lower diffusion distance which limit lipid oxidation and nitration. Besides decomposing before reaching
the site of lipid reaction it may not be able to diffuse into hydrophobic compartments due to its negative
charge [26]. This mechanism is supported by O’Donnel et al. studies in which CO2 inhibits both oxida-
tion and nitration of linoleate in cholate-solubilised micelles [33]. In our study we observed a decrease
of CO2 concentrations when blood was incubated with SpermineNONOate 10−7 M, possibly due to its
reaction with ONOO−.
When blood was incubated in presence of SpermineNONOate 10−5 M there was a significant decrease
of lipid fluidity of hydrophobic zone of erythrocyte membrane and a non-significant increase of lipid
peroxidation (Fig. 1). The decrease of lipid fluidity is probably due to the increase of lipid peroxidation.
The increase of lipid peroxidation may be caused by increased production of peroxynitrite anion from the
reaction between NO and superoxide anion. Studies using pure lipids (linoleic acid, phosphatidyl choline
liposomes, cholesteryl linoleate and free cholesterol) have shown that ONOO− can cause formation of
several lipid oxidation products including, conjugated dienes malonyldialdehyde, lipid peroxides, lipid
hydroxides, F2-isoprostanes and oxysterols [33]. These reactions may justify the observed decrease of
membrane lipid fluidity, although no changes were verified for erythrocyte deformability. When blood
was incubated with SpermineNONOate 10−5 M there was a decrease of p50 similar to that occurred with
SpermineNONOate 10−7 M, but the CO2 concentration was similar to control. However metHb slightly
increase and it is known that methemoglobin shift the oxygen dissociation curve to the left which means
decrease of p50 and increase of oxygen–hemoglobin affinity [11,27].
When blood was incubated with SpermineNONOate 10−4 M and 10−3 M there was a non-significant
concentration dependent decrease of lipid peroxidation comparing with SpermineNONOate 10−5 M. The
same was verified with membrane lipid fluidity that increased. When blood aliquots were incubated with
SpermineNONOate 10−3 M the membrane fluidity and lipid peroxidation were similar to control blood
aliquots. These profile may be justified by NO decreasing lipid peroxidation. It was reported that when
concentration of NO exceeds that of superoxide anion, lipid peroxidation can be inhibited by NO with
a concurrent formation of nitrated lipid radical termination products [39]. However at this concentration
there was a significant decrease of erythrocyte deformability at low shear stress values. Additionally,
for these concentrations of NO there was a significant and concentration dependent increase of methe-
moglobin formation and consequently a decrease of p50 values. The formation of methemoglobin is
derived from reaction of NO with oxyhemoglobin with formation of methemoglobin and nitrate an-
ion [20]. The high accumulation verified only for the higher concentrations of NO may be justified by
the generation of methemoglobin up to ability of methemoglobin reductase to reduces it back to reduced
hemoglobin. These changes in oxygen dissociation curve may be particularly important in pathological
conditions like sepsis where there is an abnormality of tissue oxygenation and levels of NO are equal or
higher than 10−5 M [4,10,32,44]. Despite the maldistribution of blood flow [5] it is verified a decrease
in oxygen extraction by compromising oxygen delivery [15]. In clinical and experimental models of sep-
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sis [21,23,46] it has been verified a significant increase of membrane lipid viscosity (decrease of fluidity)
and decrease of erythrocyte deformability.
5. Conclusion
In conclusion, depending of NO concentrations there is different effects mediated by NO or its metabo-
lites. At lower concentrations of 10−7 M and 10−6 M NO do not change membrane lipid fluidity and per-
oxidation and increases erythrocyte deformability which in vivo could facilitate erythrocyte passage in
narrow capillaries. At NO 10−5 M there is decrease of membrane fluidity, increase of lipid peroxidation
and decrease of p50 which in vivo could decrease oxygen delivery to tissues by decreasing oxygen disso-
ciation from hemoglobin. At NO 10−3 M there is an increase of methemoglobin and decrease of oxygen
dissociation from hemoglobin and of erythrocyte deformability which could impair tissue oxygenation
joining to hypotension state verified in vivo with these NO concentrations.
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